Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Women of all ages will get round-the-clock access to comprehensive treatment
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Proposed combination enhances Pfizer’s position as a leading company in oncology
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Digital success is contingent on the way a company organizes itself around technology
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
